Loulergue, Pierre <br/><br/>
Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma.  [electronic resource] 

 -  AIDS (London, England)  Jun 2008 
 - 1237-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e328300ca98  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--pharmacokinetics<br/>Contraindications<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Docetaxel<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Eyelid Neoplasms--drug therapy<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--pharmacokinetics<br/>Humans<br/>Male<br/>Neutropenia--chemically induced<br/>Ritonavir--pharmacokinetics<br/>Sarcoma, Kaposi--drug therapy<br/>Taxoids--pharmacokinetics